In our previous research, we found that the TIGIT expression of CD8+ T cells in the bone marrow and peripheral blood of AML patients was higher than that in HIs (43), suggesting that TIGIT may play an important role in T cell dysfunction in leukemia patients. Here, CD8A is linked to acute myeloid leukemia.